Abbott India Ltd

Abbott India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Abbott India Ltd

₹ 21,770 0.81%
29 Mar - close price
abbott.co.in BSE: 500488 NSE : ABBOTINDIA
About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]

Key Points

Abbott Group
The company is a part of Abbott Laboratories. The group has a presence in 160+ countries across the globe with a legacy of 130+ years.[1] [2]

Website BSE NSE
  • Market Cap ₹ 46,270 Cr.
  • Current Price ₹ 21,770
  • High / Low ₹ 22,499 / 16,156
  • Stock P/E 49.8
  • Book Value ₹ 1,277
  • Dividend Yield 0.67 %
  • ROCE 38.4 %
  • ROE 29.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 23.6% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.0%
  • Company has been maintaining a healthy dividend payout of 82.5%

Cons

  • Stock is trading at 17.0 times its book value
  • The company has delivered a poor sales growth of 11.1% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
1,078 961 1,064 1,055 1,095 1,096 1,218 1,222 1,224 1,255 1,304 1,379 1,326
839 823 831 814 854 890 953 962 955 961 1,034 1,036 1,010
Operating Profit 240 138 233 241 242 206 265 260 269 294 270 343 316
OPM % 22% 14% 22% 23% 22% 19% 22% 21% 22% 23% 21% 25% 24%
28 28 28 22 15 16 19 18 19 21 26 34 40
Interest 2 3 4 5 4 5 5 5 4 5 4 4 4
Depreciation 15 15 14 14 15 15 16 16 17 17 17 17 18
Profit before tax 251 149 242 244 238 202 264 257 267 292 275 355 335
Tax % 25% 25% 26% 26% 26% 24% 26% 25% 25% 28% 25% 25% 26%
Net Profit 187 111 180 181 177 152 196 192 199 211 206 266 247
EPS in Rs 87.86 52.22 84.87 85.05 83.36 71.75 92.13 90.51 93.74 99.49 96.77 124.95 116.16
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
990 1,490 1,653 2,276 2,289 2,614 2,903 3,298 3,679 4,093 4,310 4,919 5,265
920 1,315 1,451 2,009 1,977 2,250 2,505 2,774 3,074 3,336 3,388 3,832 4,041
Operating Profit 70 176 202 267 312 365 398 525 605 757 922 1,088 1,224
OPM % 7% 12% 12% 12% 14% 14% 14% 16% 16% 18% 21% 22% 23%
36 19 33 49 48 50 57 117 113 114 81 77 121
Interest 0 0 0 0 0 3 2 4 2 9 18 19 17
Depreciation 11 15 19 22 15 14 16 16 17 60 58 66 70
Profit before tax 94 180 215 295 344 398 436 621 699 803 926 1,080 1,258
Tax % 35% 33% 33% 33% 34% 36% 37% 35% 36% 26% 25% 26%
Net Profit 61 120 145 198 229 255 277 401 450 593 691 799 929
EPS in Rs 44.56 56.66 68.10 93.39 107.75 120.12 130.19 188.82 211.93 279.04 325.04 375.87 437.37
Dividend Payout % 38% 30% 25% 25% 29% 29% 31% 29% 31% 90% 85% 73%
Compounded Sales Growth
10 Years: 13%
5 Years: 11%
3 Years: 10%
TTM: 11%
Compounded Profit Growth
10 Years: 21%
5 Years: 24%
3 Years: 22%
TTM: 26%
Stock Price CAGR
10 Years: 32%
5 Years: 32%
3 Years: 15%
1 Year: 29%
Return on Equity
10 Years: 26%
5 Years: 27%
3 Years: 28%
Last Year: 29%

Balance Sheet

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
14 21 21 21 21 21 21 21 21 21 21 21 21
Reserves 292 523 626 767 916 1,174 1,366 1,672 1,987 2,410 2,581 2,799 2,693
0 0 0 0 0 0 0 0 0 175 153 152 129
148 253 260 351 436 421 679 723 932 940 1,086 1,253 1,257
Total Liabilities 453 797 907 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,100
50 80 109 98 96 108 110 81 105 270 251 271 249
CWIP 1 0 1 1 4 3 6 2 1 2 1 1 5
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
403 717 798 1,040 1,274 1,505 1,950 2,333 2,835 3,275 3,589 3,952 3,846
Total Assets 453 797 907 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,100

Cash Flows

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
46 24 101 155 215 249 307 153 499 626 727 948
-16 56 -59 -144 -187 -77 -155 -215 -257 -401 -72 -396
-27 -42 -42 -42 -58 -80 -90 -102 -143 -217 -582 -637
Net Cash Flow 3 38 1 -31 -30 91 62 -165 99 8 73 -86

Ratios

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 24 32 31 18 21 20 22 29 27 28 21 21
Inventory Days 73 108 99 101 107 91 107 112 106 83 110 94
Days Payable 33 51 38 38 54 56 101 92 116 104 116 122
Cash Conversion Cycle 64 89 92 80 74 54 28 49 17 8 14 -6
Working Capital Days 25 46 49 36 30 32 21 63 22 14 7 -4
ROCE % 33% 42% 34% 39% 40% 38% 34% 41% 37% 35% 35% 38%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
1.64 1.34 1.15 1.10 1.01 0.25 0.24 0.22 0.22 0.20 0.20 0.20
6.08 5.98 6.34 5.82 5.53 6.74 6.88 6.76 7.52 7.95 7.85 8.38
17.30 17.69 17.52 18.09 18.47 18.03 17.89 18.04 17.27 16.86 16.95 16.42

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls